Formulary Search Results for: PONATINIB
8.1.5 Other antineoplastic drugs - View Category
Total Formulary
PONATINIB (tablets)
Restrictions:
Restricted to specialist use in accordance with regional protocol for the indications listed in the Prescribing Notes below
Prescribing Notes:
Chronic myeloid leukaemia (CML):
The treatment of chronic phase, accelerated phase or blast phase chronic myeloid leukaemia (CML) in adults:
- resistant to dasatinib or nilotinib
- who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate
- who have the T215 mutation
Philadelphia chromosome positive acute lymphoblastic leukaemia (Ph+ ALL)
The treatment of Philadelphia chromosome positive acute lymphoblastic leukaemia in adults:
- who are resistant to dasatinib, intolerant of dasatinib and for whom subsequent treatment with imatinib is clinically appropriate
- with the T3151 mutation
To access the regional protocol click here